Ever Supreme Bio Technology Co., Ltd reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 143.71 million compared to TWD 27.14 million a year ago. Net income was TWD 233.22 million compared to net loss of TWD 13.34 million a year ago. Basic earnings per share from continuing operations was TWD 3.4364 compared to basic loss per share from continuing operations of TWD 0.2182 a year ago. Diluted earnings per share from continuing operations was TWD 3.4 compared to diluted loss per share from continuing operations of TWD 0.2182 a year ago.
For the nine months, sales was TWD 283.75 million compared to TWD 44.52 million a year ago. Net income was TWD 287.46 million compared to net loss of TWD 80.48 million a year ago. Basic earnings per share from continuing operations was TWD 4.2455 compared to basic loss per share from continuing operations of TWD 1.3091 a year ago. Diluted earnings per share from continuing operations was TWD 4.2 compared to diluted loss per share from continuing operations of TWD 1.3091 a year ago.